Skip to main content

Table 7 Prediction of subsequent 90-day mortality

From: Proteinuria can predict prognosis after liver transplantation

Predictive factors

Cutoff point

Youden index

Sensitivity (%)

Specificity (%)

Overall correctness (%)

Proteinuria

 On admission

positive

0.16

28

88

58

 Postoperative day 1

positive

0.22

64

58

61

 Postoperative day 7

positive

0.51

85

66

76

 Postoperative day 14

positive

0.55

90

65

77

Child-Pugh points

 On admission

12

0.17

95

22

59

 Postoperative day 1

10

0.26

90

37

64

 Postoperative day 7

9

0.42

60

82

71

 Postoperative day 14

8

0.42

50

92

71

MELD score

 On admission

15

0.19

65

56

61

 Postoperative day 1

22

0.27

60

71

66

 Postoperative day 7

20

0.58

69

87

78

 Postoperative day 14

23

0.62

75

87

81

RIFLE

 On admission

I category

0.04

7

97

52

 Postoperative day 1

I category

0.20

57

64

61

 Postoperative day 7

I category

0.56

72

82

77

 Postoperative day 14

R category

0.60

74

82

78

SOFA

 On admission

5

0.23

52

71

62

 Postoperative day 1

11

0.41

77

64

71

 Postoperative day 7

7

0.70

83

87

84

 Postoperative day 14

7

0.69

85

84

84

Proteinuria plus SOFA

 On admission

5

0.26

57

70

63

 Postoperative day 1

12

0.54

79

75

77

 Postoperative day 7

8

0.72

85

85

85

 Postoperative day 14

8

0.72

89

83

86

Proteinuria plus nonrenal SOFA

 On admission

5

0.26

54

76

63

 Postoperative day 1

12

0.54

54

100

77

 Postoperative day 7

8

0.68

86

82

84

 Postoperative day 14

7

0.67

100

67

84

  1. Optimal cutoff points for predicting 3-month mortality were derived from receiver operator characteristic analysis. On admission (pre-transplant), post-transplant day 1, 7, and 14, the Youden index and overall correctness for predicting 3-month mortality were higher for the proteinuria plus SOFA score than those for the proteinuria, Child-Pugh points, MELD score, RIFLE criteria, SOFA, and proteinuria plus nonrenal SOFA scores
  2. Abbreviation: MELD model for end-stage liver disease, SOFA sequential organ failure assessment